Seres Therapeutics Reports Inducement Grants Under Nasdaq Li

Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that on April 5, 2023, the Compensation and Talent Committee of Seres’ board of directors granted... | April 7, 2023

Related Keywords

, Nasdaq , Talent Committee Of Sere , Seres Therapeutics Inc , Seres Therapeutics , Talent Committee , Inducement Award Plan , Inducement Plan , Nasdaq Listing Rule , Nc Stock Exchange , News , Information , Press Release , Heres , Reading , Icrobiome , Herapeutics , Oday , Nnounced , Hat , N , Pril , The , Compensation , End , Talent , Committee , F , Board , Irectors Mcrb Us81750r1023 ,